Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Goodwill (2016 - 2025)

Historic Goodwill for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $144.3 million.

  • Usana Health Sciences' Goodwill rose 73907.89% to $144.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.3 million, marking a year-over-year increase of 73907.89%. This contributed to the annual value of $144.2 million for FY2024, which is 74298.91% up from last year.
  • As of Q3 2025, Usana Health Sciences' Goodwill stood at $144.3 million, which was up 73907.89% from $127.4 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Goodwill ranged from a high of $144.3 million in Q3 2025 and a low of $582000.0 during Q3 2022
  • In the last 5 years, Usana Health Sciences' Goodwill had a median value of $17.4 million in 2021 and averaged $41.0 million.
  • In the last 5 years, Usana Health Sciences' Goodwill tumbled by 9666.8% in 2022 and then skyrocketed by 279673.54% in 2023.
  • Quarter analysis of 5 years shows Usana Health Sciences' Goodwill stood at $17.5 million in 2021, then fell by 0.81% to $17.4 million in 2022, then dropped by 1.53% to $17.1 million in 2023, then soared by 742.99% to $144.2 million in 2024, then increased by 0.08% to $144.3 million in 2025.
  • Its last three reported values are $144.3 million in Q3 2025, $127.4 million for Q2 2025, and $144.2 million during Q1 2025.